Skip to main content
PharmaResearch Co., Ltd. logo

PharmaResearch Co., Ltd. — Investor Relations & Filings

Ticker · 214450 ISIN · KR7214450009 KO Manufacturing
Open in API
Filings indexed 258 across all filing types
Latest filing 2026-02-04 Earnings Release
Country KR South Korea
Listing KO 214450

About PharmaResearch Co., Ltd.

https://pharmaresearch.co.kr/en/

PharmaResearch Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. It utilizes marine biotechnology to develop and commercialize refined raw materials for cell and tissue regeneration. The company's activities also encompass the manufacturing of medical devices and providing consulting services for the development, licensing, and registration of pharmaceuticals. PharmaResearch focuses on creating innovative biological products to enhance human health and quality of life.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a 'Change in Sales or Profit/Loss Structure of 30% or more'. This is a standard preliminary earnings announcement (Earnings Release) in the Korean market, providing key financial highlights (revenue, operating profit, net income) for the fiscal year 2025 compared to 2024. It explicitly states that these are preliminary figures subject to audit, which is characteristic of an Earnings Release (ER). FY 2025
2026-02-04 Korean
[기재정정]결산실적공시예고
Report Publication Announcement Classification · 1% confidence The document is a short regulatory filing (786 characters) titled '결산실적공시 예고' (Notice of Earnings Release Schedule). It informs investors about the upcoming date for the release of the company's 2025 annual financial results and notes a change in the board meeting schedule. Since it is an announcement regarding the timing of a future report rather than the report itself, it falls under the Report Publication Announcement (RPA) category.
2026-01-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider holdings and transactions by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2026-01-27 Korean
결산실적공시예고
Report Publication Announcement Classification · 1% confidence The document is a short announcement titled '결산실적공시 예고' (Notice of Earnings Release Schedule). It informs shareholders of the upcoming date (2026-02-09) for the release of the 2025 fiscal year-end financial results. Since it is a brief notification regarding the timing of a future report rather than the financial report itself, it falls under the Report Publication Announcement (RPA) category.
2026-01-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by Morgan Stanley & Co. International plc in Pharmaresearch Co., Ltd. The document includes specific sections for reporting ownership percentages, changes in holdings, and the purpose of the investment (simple investment). This fits the 'Major Shareholding Notification' category.
2026-01-06 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the record date. Given it is a specific regulatory announcement that does not fit into the other categories like 'AGM-R' (which implies presentation materials) or 'PSI' (which implies proxy solicitation materials), it is best classified as a general regulatory filing.
2025-12-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.